Czech Republic PharmaBoardroom’s latest report: Healthcare & Life Sciences Review: Czech Republic is available for download now. Home to a USD 3.38 billion pharma market, one of Central and Eastern Europe’s most high-performing healthcare systems, and one of the region’s leading economies, the Czech Republic’s healthcare and life sciences market is…
UAE PharmaBoardroom’s latest country report gives an up-to-date and comprehensive overview of one of the most strategic and innovation-friendly nations on earth: The UAE. The UAE’s pharma market was predicted to grow to USD four billion in 2020, representing a CAGR of 8.5 percent from 2019. The country sits at…
Hungary In line with its status as one of Europe’s most dynamic economies, Hungary is aiming to boost both its life sciences industry and the level of healthcare it provides to its citizens. Year-on-year GDP growth stood at 4.8 percent in 2019, driven on by a burgeoning domestic pharmaceuticals industry…
China This new issue of China Healthcare and Life Sciences Review (compiled in December 2019) provides a retrospective of the tremendous gains the Chinese healthcare industry made in 2019 while simultaneously anticipating the challenges and opportunities on the horizon in the new decade. From the steady national expansion of pilot…
Puerto Rico Puerto Rico had to rebuild itself – in many cases quite literally – after the devastation wrought by Hurricane Maria in 2017. However, despite the havoc that Maria brought to the island’s telecommunications, energy and water supply, the jewel in Puerto Rico’s crown – its pharmaceutical industry – remained largely…
Report PharmaBoardroom had the opportunity to sit down with over six hundred key stakeholders in the life sciences industry across fifteen different countries in 2019. The culmination of time spent in these countries and the insights gained from the interviews we conducted resulted in the publishing of thirteen country reports. Here…
Sweden Belying its small size, the Nordic nation of Sweden punches well above its weight in scientific innovation. Despite boasting a population of just 10 million and a marginal position on the most northerly fringes of the EU, Sweden has been ranked the second most innovative country in the world by…
Taiwan Long overshadowed by larger and more well-known neighbours, the island of Taiwan is nonetheless cultivating an enviable reputation at the forefront of some of the most innovative trends shaping global healthcare today. From artificial intelligence to blockchain, the internet of things and regenerative medicine, Taiwanese firms – with the…
Thailand PharmaBoardroom’s latest report: Healthcare & Life Sciences Review: Thailand is available for download now. Thailand is in the midst of an economic transformation with healthcare at its heart. With four years of around three-four percent annual GDP growth behind it, ASEAN’s second-largest economy has implemented an ‘Industry 4.0’ policy through which…
China Download our latest pharma country report on China here 2019 is a landmark year for China, marking not only the 70th anniversary of the establishment of the People’s Republic of China by Chairman Mao Zedong in 1949 but also the economic ‘opening up’ and liberalization in 1979 by Premier…
Spain Building on the topics covered in our March 2019 report, the latest edition of Healthcare & Life Sciences Review Spain takes a closer look at the broader Spanish life sciences value chain. With the Iberian nation enjoying an economic rebound, pharmaceutical multinationals are once again seeing Spain as a…
Egypt In our latest Healthcare & Life Sciences Review, we look at Egypt. With a swathe of economic reforms in the pipeline, including the launch of the Universal Healthcare Act, which aims to provide health coverage to all of Egypt’s 98 million inhabitants, as well as various national campaigns aimed at…
See our Cookie Privacy Policy Here